In non-alcoholic fatty liver disease (NAFLD), insulin resistance leads to abnormal accumulation of fat in the liver, which further triggers inflammation and liver cell damage, eventually leading to cirrhosis and liver failure.500 The IR/PI3K/Akt signaling pathway is crucial for the development of NAFLD. Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.